Bristol-Myers Squibb
BMY
BMY
1,689 hedge funds and large institutions have $66.2B invested in Bristol-Myers Squibb in 2018 Q2 according to their latest regulatory filings, with 93 funds opening new positions, 578 increasing their positions, 768 reducing their positions, and 134 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,689
Holders Change
-55
Holders Change %
-3.15%
% of All Funds
38.72%
Holding in Top 10
39
Holding in Top 10 Change
-20
Holding in Top 10 Change %
-33.9%
% of All Funds
0.89%
New
93
Increased
578
Reduced
768
Closed
134
Calls
$1.74B
Puts
$1.49B
Net Calls
+$246M
Net Calls Change
-$822M
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$459M |
| 2 |
Harris Associates
Chicago,
Illinois
|
+$430M |
| 3 |
BlackRock
New York
|
+$416M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$407M |
| 5 |
D.E. Shaw & Co
New York
|
+$296M |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$488M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$350M |
| 3 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
-$254M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$221M |
| 5 |
Renaissance Technologies
New York
|
-$220M |